DESFLURANE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Desflurane, and when can generic versions of Desflurane launch?
Desflurane is a drug marketed by Shanghai Hengrui and is included in one NDA.
The generic ingredient in DESFLURANE is desflurane. There are three drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the desflurane profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Desflurane
A generic version of DESFLURANE was approved as desflurane by SHANGHAI HENGRUI on February 26th, 2018.
Summary for DESFLURANE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 55 |
| Clinical Trials: | 251 |
| Patent Applications: | 1,623 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | DESFLURANE at DailyMed |
Recent Clinical Trials for DESFLURANE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Wonkwang University Hospital | N/A |
| Tianjin First Central Hospital | Phase 4 |
| Daegu Catholic University Medical Center | N/A |
Pharmacology for DESFLURANE
| Drug Class | General Anesthetic |
| Physiological Effect | General Anesthesia |
Anatomical Therapeutic Chemical (ATC) Classes for DESFLURANE
Paragraph IV (Patent) Challenges for DESFLURANE
| Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
|---|---|---|---|---|---|---|
| SUPRANE | Inhalation | desflurane | 99.9% | 020118 | 1 | 2008-09-11 |
US Patents and Regulatory Information for DESFLURANE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shanghai Hengrui | DESFLURANE | desflurane | LIQUID;INHALATION | 208234-001 | Feb 26, 2018 | AN | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
